Clinical Trial Update: Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ORADUR-Methylphenidate for safety and efficacy in children and adolescents with ADHD has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• ORADUR-Methylphenidate (methylphenidate)

Snippet

Sponsor: Orient Pharma Co., Ltd. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED